Northern Trust
TYRA icon

Northern Trust’s Tyra Biosciences TYRA Stock Holding History

Northern Trust’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.37M Buy
218,508
+17,552
+9% +$568K ﹤0.01% 2174
2025
Q4 		$5.28M Sell
200,956
-7,530
-4% -$138K ﹤0.01% 2438
2025
Q3 		$2.92M Buy
208,486
+3,178
+2% +$36.2K ﹤0.01% 2824
2025
Q2 		$1.96M Sell
205,308
-11,139
-5% -$106K ﹤0.01% 2999
2025
Q1 		$2.01M Sell
216,447
-6,317
-3% -$81.7K ﹤0.01% 2925
2024
Q4 		$3.1M Buy
222,764
+8,411
+4% +$153K ﹤0.01% 2784
2024
Q3 		$5.04M Buy
214,353
+58,902
+38% +$1.24M ﹤0.01% 2468
2024
Q2 		$2.49M Sell
155,451
-1,021
-0.7% -$17.6K ﹤0.01% 2783
2024
Q1 		$2.57M Buy
156,472
+4,222
+3% +$69.2K ﹤0.01% 2834
2023
Q4 		$2.11M Buy
152,250
+10,651
+8% +$138K ﹤0.01% 2985
2023
Q3 		$1.95M Buy
141,599
+1,431
+1% +$21.2K ﹤0.01% 2957
2023
Q2 		$2.39M Buy
140,168
+32,626
+30% +$473K ﹤0.01% 2916
2023
Q1 		$1.73M Buy
107,542
+1,775
+2% +$21.1K ﹤0.01% 3001
2022
Q4 		$804K Buy
105,767
+1,959
+2% +$13.9K ﹤0.01% 3341
2022
Q3 		$912K Buy
103,808
+674
+0.7% +$6.17K ﹤0.01% 3331
2022
Q2 		$738K Buy
103,134
+3,030
+3% +$24.1K ﹤0.01% 3418
2022
Q1 		$1.07M Sell
100,104
-3,389
-3% -$40.2K ﹤0.01% 3389
2021
Q4 		$1.46M Buy
+103,493
New +$2.06M ﹤0.01% 3388

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Northern Trust's TYRA Position: Q1 2026 in Review

Northern Trust increased its Tyra Biosciences (TYRA) stake by 8.7% in Q1 2026, buying an estimated $568K and bringing the position to 218,508 shares worth $8.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Northern Trust first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Northern Trust held 218,508 shares of Tyra Biosciences worth $8.37M as of Q1 2026.
  • Northern Trust bought 17,552 Tyra Biosciences shares in Q1 2026, an estimated $568K.
  • Tyra Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2174 holding.
  • Northern Trust first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.